Covaxin
Only 12 percent of people in 18-59 age group have taken precaution dose for COVID 19 vaccine
Govt nod for Corbevax as booster for adults vaccinated with Covishield, Covaxin soon
Govt panel recommends Corbevax as booster for adults vaccinated with Covishield, Covaxin
Bharat Biotech expects regulator's nod for intranasal COVID-19 vaccine in Aug
Free Covid precaution doses for 18-59 age group from July 15 at govt centres: officials
Covaxin proven safe for children of 2-18 years age group in phase III study: Bharat Biotech
Covaxin safe, well-tolerated in 2-18 years age-group: Bharat Biotech